Melanocortin receptor agonists, penile erection, and sexual motivation: Human studies with Melanotan II

International Journal of Impotence Research

Volumn 12, Issue , 2000, Pages S74-S79

  Wessells, H ^a   Levine, N ^a   Hadley, M E ^b   Dorr, R ^a   Hruby, V ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Impotence; MSH; Penile erection; Sex behavior

Indexed keywords

HORMONE RECEPTOR STIMULATING AGENT; MELANOCORTIN RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; MELANOTAN 2; UNCLASSIFIED DRUG;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG STRUCTURE; ERECTILE DYSFUNCTION; HUMAN; IMPOTENCE; MALE; NAUSEA; PENIS ERECTION; PRIORITY JOURNAL; QUESTIONNAIRE; SEXUAL BEHAVIOR; YAWNING;

ADOLESCENT; ADULT; AGED; ALPHA-MSH; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; HUMANS; IMPOTENCE; LIBIDO; MALE; MIDDLE AGED; NAUSEA; PENILE ERECTION; PEPTIDES, CYCLIC; REACTION TIME; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 0033779983     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900582     Document Type: Article

References (18)

1. Bertolini A, Gessa GL, Ferrari W. Penile erection and ejaculation: A central effect of ACTH-like peptides in mammals. In: Sandler M, Gessa GL (eds) Sexual behavior: Pharmacology and biochemistry. Raven Press: New York, 1975.
2. Argiolas A, Melis MR, Gessa GL. Yawning and penile erection: Central dopamine-oxytocin-adrenocorticotropin connection. Ann N Y Acad Sci 1988; 525: 330-337.
3. Bertolini A, Vergoni W, Gessa GL, Ferrari W. Induction of sexual excitement by the action of adrenocorticotrophic hormone in brain. Nature 1969; 221: 667-669.
4. Thody AJ, Wilson GA, Everard D. Facilitation and inhibition of sexual receptivity in the female rat by a-MSH. Physiol Behav 1979; 22: 447-450.
5. Vergoni AV et al. Differential influence of a selective melanocortin MC4 receptor antagonist (HS014) on melano-cortin-induced behavioral effects in rats. Eur J Pharmacol 1998; 362: 95-101.
6. van der Kraan M et al. Expression of melanocortin-5 receptor in secretory epithelia supports a functional role in exocrine and endocrine glands. Endocrinology 1998; 139: 2348-2355.
7. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD. The cloning of a family of genes that encode the melanotropin receptors. Science 1992; 257: 1248-1251.
8. Chhajlani V, Wikberg JES. Molecular cloning and expression of the human melanocyte hormone receptor cDNA. FEBS Lett. 1992; 309: 417-420.
9. Gantz I et al. Molecular cloning of a novel melanocortin receptor. J Biol Chem 1993; 268: 8246-8250.
10. Fan W et al. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997; 385: 165-168.
11. Levine N et al. Induction of skin tanning by subcutaneous administration of a potent synthetic melanotropin. JAMA 1991; 266: 2730-2736.
12. Ugwu SO et al. Skin pigmentation and pharmacokinetics of Melanotan-I in humans. Biopharmaceut Drug Disposit 1997; 18: 259-269.
13. Wessells H et al. Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: Double blind placebo controlled crossover study. J Urol 1998; 160: 389-393.
14. Dorr RT et al. Evaluation of Melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci 1996; 58: 1777-1784.
15. Wessells H et al. Effect of an alpha melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology, (in press).
16. Impotence: National Institutes of Health Consensus Development Panel on Impotence. JAMA 1993; 270: 83-90.
17. Al-Obeidi F, de La Castrucci AM, Hadley ME, Hruby VJ. Potent and prolonged acting cyclic lactam analogues of α-melanotropin: Design based on molecular dynamics. J Med Chem 1989; 32: 2555-2561.
18. Rosen RC et al. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.